Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited said it has not observed any material changes in the bankruptcy liquidation of its 55%-owned subsidiary, Tianjin Shin Poong Pharmaceutical Co., Ltd., since its previous monthly update on Aug, 31 2026.

The company noted that it will continue to monitor the proceedings, liaise with the court-appointed administrator, and publish further monthly updates in line with Rule 704(23) of the Singapore Exchange Listing Manual. It also advised shareholders and potential investors to exercise caution when trading its shares.